Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 2
1989 1
1990 2
1991 4
1992 1
1993 3
1994 1
1995 3
1996 1
1997 1
1998 1
1999 3
2000 5
2001 4
2002 4
2003 5
2004 3
2005 2
2006 6
2008 2
2009 2
2010 3
2011 2
2012 4
2013 4
2014 3
2015 4
2016 3
2017 4
2018 5
2019 9
2020 9
2021 12
2022 9
2023 11
2024 10
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Rha SY, Oh DY, Yañez P, Bai Y, Ryu MH, Lee J, Rivera F, Alves GV, Garrido M, Shiu KK, Fernández MG, Li J, Lowery MA, Çil T, Cruz FM, Qin S, Luo S, Pan H, Wainberg ZA, Yin L, Bordia S, Bhagia P, Wyrwicz LS; KEYNOTE-859 investigators. Rha SY, et al. Lancet Oncol. 2023 Nov;24(11):1181-1195. doi: 10.1016/S1470-2045(23)00515-6. Epub 2023 Oct 21. Lancet Oncol. 2023. PMID: 37875143 Clinical Trial.
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.
Valtorta E, Martino C, Sartore-Bianchi A, Penaullt-Llorca F, Viale G, Risio M, Rugge M, Grigioni W, Bencardino K, Lonardi S, Zagonel V, Leone F, Noe J, Ciardiello F, Pinto C, Labianca R, Mosconi S, Graiff C, Aprile G, Frau B, Garufi C, Loupakis F, Racca P, Tonini G, Lauricella C, Veronese S, Truini M, Siena S, Marsoni S, Gambacorta M. Valtorta E, et al. Among authors: garufi c. Mod Pathol. 2015 Nov;28(11):1481-91. doi: 10.1038/modpathol.2015.98. Epub 2015 Oct 9. Mod Pathol. 2015. PMID: 26449765 Free article. Clinical Trial.
Cord entanglement.
Salvi S, De Carolis S, Garofalo S, Del Sordo G, Garufi C, De Carolis MP. Salvi S, et al. Among authors: garufi c. Arch Dis Child Fetal Neonatal Ed. 2014 Nov;99(6):F457. doi: 10.1136/archdischild-2013-305861. Epub 2014 Apr 19. Arch Dis Child Fetal Neonatal Ed. 2014. PMID: 24747306 No abstract available.
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAFV600E wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial.
Ciardiello D, Boscolo Bielo L, Napolitano S, Martinelli E, Troiani T, Nicastro A, Latiano TP, Parente P, Maiello E, Avallone A, Normanno N, Pisconti S, Nisi C, Bordonaro R, Russo AE, Tamburini E, Toma I, Lotesoriere C, Vallarelli S, Zampino MG, Fazio N, Curigliano G, De Vita F, Ciardiello F, Martini G; CAPRI-2 GOIM study group. Ciardiello D, et al. Ann Oncol. 2024 Dec;35(12):1105-1115. doi: 10.1016/j.annonc.2024.08.2334. Epub 2024 Aug 29. Ann Oncol. 2024. PMID: 39214459
Complementemia in pregnancies with antiphospholipid syndrome.
Tabacco S, Giannini A, Garufi C, Botta A, Salvi S, Del Sordo G, Benedetti Panici P, Lanzone A, De Carolis S. Tabacco S, et al. Among authors: garufi c. Lupus. 2019 Nov;28(13):1503-1509. doi: 10.1177/0961203319882507. Epub 2019 Oct 17. Lupus. 2019. PMID: 31623520
[Chronochemotherapy].
Dogliotti L, Garufi C, Iacobelli S. Dogliotti L, et al. Among authors: garufi c. Tumori. 2000 May-Jun;86(3 Suppl):S32-6. doi: 10.1177/03008916000863S111. Tumori. 2000. PMID: 10969615 Review. Italian. No abstract available.
Antibody profiles in the mosaic of 'seronegative' APS syndrome.
Truglia S, Riitano G, Mancuso S, Recalchi S, Rapino L, Garufi C, Manganelli V, Garofalo T, Misasi R, Alessandri C, Sorice M, Longo A, Conti F, Capozzi A. Truglia S, et al. Among authors: garufi c. Clin Exp Immunol. 2024 Nov 12;218(3):275-282. doi: 10.1093/cei/uxae079. Clin Exp Immunol. 2024. PMID: 39192704 Free PMC article.
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial.
Piscaglia F, Masi G, Martinelli E, Cabibbo G, Di Maio M, Gasbarrini A, Iavarone M, Antonuzzo L, Mazzaferro V, Ballestrero A, Garufi C, Bergamo F, Celsa C, Marino D, Tovoli F, Ponziani FR, Pressiani T, Astolfi C, Gazzoli GC, Ciardiello F, Daniele B, Rimassa L. Piscaglia F, et al. Among authors: garufi c. ESMO Open. 2025 Feb;10(2):104110. doi: 10.1016/j.esmoop.2024.104110. Epub 2025 Jan 27. ESMO Open. 2025. PMID: 39874903 Free PMC article. Clinical Trial.
[Chronotherapy].
Garufi C, Aschelter AM, Zappalà AR, Vanni B, Terzoli E. Garufi C, et al. Tumori. 2001 Nov-Dec;87(6):A26-7. Tumori. 2001. PMID: 11995702 Review. Italian. No abstract available.
140 results